Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease

Fig. 1

Antibody response following vaccination with the second dose of coronavirus disease 2019 (COVID-19) vaccine. The median antibody titers after second vaccination were significantly lower in the HD group than in the CKD G4 group (p < 0.01). There was no significant difference in the antibody titers between the CKD G4 and G5 groups

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us